Cardiovascular Pathology
Cardiovascular Pathology

Cardiovascular Pathology

by Carlo Raj, MD
(11)

Learn cardiovascular pathology online and get the most out of your study time!

Lecturio’s integrated cardiovascular pathology course held by MD Carlo Raj will not only equip you with knowledge about the most important diseases related to the cardiovascular system, but will also build bridges to the related medical sciences, and thus provide you with the deepest understanding of all cardiovascular pathology topics. We are convinced that learning cardiovascular pathology has never been so inspirational, comprehensive and fun.

Upon completion of this course you will be able to easily answer all pathology questions regarding cardiovascular diseases. This is very important because cardiovascular pathology is one of the central topics in the USMLE Step 1 exam.

The course will cover the following high yield topics, among others:

  • Ischemic heart disease pathology and management
  • Electrocardiogram pathology and management
  • Valvular heart disease pathology and management
  • Myocardial disease
  • Pericardial disease
  • Cardiac arrhythmia

Before taking this course, you should already have a strong foundation in the basic sciences such as anatomy, physiology, biochemistry, microbiology & immunology, and pharmacology. MD Carlo Raj will not only familiarize you with the concepts but, in doing so, will support you in building a long-term understanding of cardiovascular pathology. As a result, you will master the boards and become a better physician.

Course Details

  • Videos 22
  • Duration 9:35 h
  • Quiz questions 99
  • Topic reviews 30

Content

Your Educators of course Cardiovascular Pathology

 Carlo Raj, MD

Carlo Raj, MD

You probably know MD Edward Goljan and his Rapid Review Pathology Series. But do you know the "new" Goljan? His name is Carlo Raj and he is currently following his mentor's footsteps by presenting you pathology as you have never experienced before.

Carlo Raj has earned his MD at the Medical University of the Americas (MUA) and continued his medical career as professor of Pathophysiology at the University of Pikeville, Kentucky, and as an international lecturer and author—both assisting MD Edward Goljan and later on his own. Today he is also CEO of Indus Intellect, whose goal it is to spread medical knowledge across the globe.


User reviews

(11)

4,1 of 5 stars
5 Stars
6
4 Stars
1
3 Stars
3
2 Stars
1
1  Star
0
 
What about valvuloplasty
By Hamed S. on 18. February 2017 for Valvular Heart Disease: Mitral Stenosis

Need to further explore surgical and percutaneous treatment options incl valvuloplasty and in which patients valve replacement vs valvuloplasty is preferred

 
More Management Discussions Needed
By Hamed S. on 18. February 2017 for Valvular Heart Disease: Aortic Stenosis

This was a well explained lecture but a trend I have noticed with these videos so far is the immense focus on physiology at the expense of diagnosis and management which is important for step 2. The avoidance of vasodilators, ACE-Inhibitors etc was glossed over. Moreover, a discussion of surgical options including valvuloplasty and percutaneous valve replacement was omitted. Common on guys if you are serious about step-2 and want people to transition from established providers like Kaplan then you need to focus more on management. I'm beginning to lose faith in these videos

 
Good lecture but what about AVNRT and AVRT
By Hamed S. on 18. February 2017 for Tachyarrhythmia: Multifocal Atrial Tachycardia and Wolff-Parkinson-White-Syndrome (WPW)

Really good talk but would have been great to discuss the choice between rate and rhythm controlled Rx as well as a section devoided to AVNRT and AVRT. I'm still a bit confused about why the management differs between these two supraventricluar tachy and WPW

 
Significant Gaps in Management
By Hamed S. on 18. February 2017 for Management of Angina and Myocardial Infarction

The lecture on management was extremely superficial and not suitable for board exams. No mention of: Newer agents such as ticagrelor/prasugrel When you would choose PCI vs thrombolysis risk stratification of NSTEMI patients with the TIMI score and subsequent angio When you would use CABG first line This talk I feel is more step 1 then step 2. Step 2 needs to focus more on decision making rather than lengthy talk on the basic pathophys I had to go back to references to Toronoto Notes to fill this gap

See all 11 user reviews with text